Bilateral Thalamic Lesions Associated With Atezolizumab-Induced Encephalitis

A 72-year-old woman was clinically diagnosed with atezolizumab-induced encephalitis.1 Her clinical features were previously described1 and here we present the autopsy findings. She had been treated with atezolizumab, an immune checkpoint inhibitor (ICI), due to a metastatic non–small-cell lung cancer diagnosis. She received her final atezolizumab injection 3 weeks after encephalitis onset, and cancer therapy ceased. Although the bilateral...